KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,750 | -5.3% | 32,326 | -4.1% | 0.02% | -4.2% |
| Q2 2023 | $3,959 | +40.6% | 33,721 | -4.1% | 0.02% | +26.3% |
| Q1 2023 | $2,815 | -4.3% | 35,165 | -5.3% | 0.02% | -13.6% |
| Q4 2022 | $2,941 | -99.9% | 37,130 | -14.4% | 0.02% | -8.3% |
| Q3 2022 | $3,024,000 | +2.0% | 43,384 | -3.9% | 0.02% | +4.3% |
| Q2 2022 | $2,964,000 | -14.8% | 45,144 | -13.7% | 0.02% | -8.0% |
| Q1 2022 | $3,480,000 | -17.0% | 52,303 | -12.7% | 0.02% | -16.7% |
| Q4 2021 | $4,192,000 | -0.8% | 59,935 | -3.5% | 0.03% | -11.8% |
| Q2 2021 | $4,224,000 | 0.0% | 62,112 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $4,224,000 | 0.0% | 62,112 | 0.0% | 0.03% | 0.0% |
| Q4 2020 | $4,224,000 | 0.0% | 62,112 | 0.0% | 0.03% | 0.0% |
| Q3 2020 | $4,224,000 | 0.0% | 62,112 | 0.0% | 0.03% | 0.0% |
| Q2 2020 | $4,224,000 | 0.0% | 62,112 | 0.0% | 0.03% | 0.0% |
| Q1 2020 | $4,224,000 | 0.0% | 62,112 | 0.0% | 0.03% | 0.0% |
| Q4 2019 | $4,224,000 | 0.0% | 62,112 | 0.0% | 0.03% | 0.0% |
| Q3 2019 | $4,224,000 | 0.0% | 62,112 | 0.0% | 0.03% | 0.0% |
| Q2 2019 | $4,224,000 | 0.0% | 62,112 | 0.0% | 0.03% | 0.0% |
| Q1 2019 | $4,224,000 | – | 62,112 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,896,645 | $150,252,217 | 6.15% |
| S Squared Technology, LLC | 108,215 | $8,572,792 | 5.80% |
| Frazier Life Sciences Management, L.P. | 999,737 | $79,199,165 | 4.92% |
| First Light Asset Management, LLC | 473,691 | $37,525,801 | 3.48% |
| Ikarian Capital, LLC | 165,900 | $13,142,598 | 3.17% |
| Soleus Capital Management, L.P. | 188,217 | $14,910,551 | 2.14% |
| Integral Health Asset Management, LLC | 115,000 | $9,110,300 | 1.91% |
| Nicholas Investment Partners, LP | 267,089 | $21,158,791 | 1.85% |
| Artal Group S.A. | 400,000 | $31,688 | 1.77% |
| Avoro Capital Advisors LLC | 1,410,000 | $111,700,200 | 1.67% |